Malaysia's Solution Group Bhd said on Thursday it has signed a term sheet agreement with the government to supply 3.5 million doses of Covid-19 vaccine jointly developed by China's CanSino Biologics Inc and Beijing Institute of Biotechnology under the Academy of Military Medical Sciences.

The company, whose website shows it is engineering as well as biopharmaceuticals business, said in a bourse filing that its wholly-owned unit Solution Biologics had signed the agreement on Jan 29 with the Health Ministry...